ArticlePathology oncology research : POR2021

Loss of ARID1A Expression as a Favorable Prognostic Factor in Early-Stage Grade 3 Endometrioid Endometrial Carcinoma Patients.

Mayumi Kobayashi Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.